Clinical Trial

Acquired Dyslexia Modeling and Treatment

Study acronym: AMT

Recruiting

Summary

This study is a low-risk, early phase 1, multicenter trial to test the use of a computational (neural network) cognitive model of reading to simulate acquired dyslexia and its treatment. The aim is to determine whether there is an advantage to receiving the treatment the model predicts to be advantageous compared to the alternative treatment. All participants will receive two full rounds of treatment. A round of treatment will consist of either phonomotor treatment (PMT) or semantic feature analysis (SFA) for 60 hours, distributed over 5 days a week for 2 hours a day.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-10-02.

Status change: Not Yet Recruiting → Recruiting 2026-05-05

Trial Details

NCT Number	NCT07209488
Lead Sponsor	Rutgers, The State University of New Jersey Collaborators: National Institute on Deafness and Other Communication Disorders (NIDCD)
Conditions	Stroke, Dyslexia, Acquired
Enrollment	12 participants
Start Date	2025-12-03
Primary Completion	2026-09 (estimated)
Study Completion	2026-09 (estimated)
Updated on ClinicalTrials.gov	2026-05-06